Rheumatoid arthritis (refractory) - abatacept (replaced by TA195)
Abatacept for the treatment of rheumatoid arthritis
Description
This guidance has been updatred and replaced by Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor
Guidance documents
Implementing this guidance
Other information
We will consult on our review plans for this guidance in July 2010
About this guidance
Technology appraisals TA141
Issued: April 2008
How this guidance was produced